Search research articles
Contact Us
Filters
Showing results (361-370 of 497) with videos related to
Page
of 50
Sort By:
Journal of Clinical Medicine
|
March 25, 2022
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
Calogero Vetro, Valeria Di Giacomo, Donato Mannina, et al.
Leukemia
|
March 4, 2005
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
S Mariani, M Muraro, F Pantaleoni, et al.
La Radiologia Medica
|
October 24, 2007
Diagnostic accuracy of 64-slice computed tomography coronary angiography in patients with low-to-intermediate risk
F Cademartiri, E Maffei, A Palumbo, et al.
British Journal of Haematology
|
July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Elena Crisà, Daniela Cilloni, Elena M Elli, et al.
La Radiologia Medica
|
October 31, 2008
Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia
F Cademartiri, A Palumbo, E Maffei, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 28, 2007
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms
S Galimberti, G A Palumbo, F Caracciolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
A Palumbo, F Gay, S Bringhen, et al.
Leukemia
|
October 31, 2003
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))
A Palumbo, S Bringhen, A Bertola, et al.
Oncogenesis
|
October 13, 2021
Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
Darko Bosnakovski, Elizabeth T Ener, Mark S Cooper, et al.
Leukemia
|
July 24, 2025
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
Andrea Duminuco, Raj Vaghela, Sukhraj Virdee, et al.
Page
of 50
Search research articles
Search
Showing results (361-370 of 497) with videos related to
Sort By:
Page
of 50
Journal of Clinical Medicine
|
March 25, 2022
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
Calogero Vetro, Valeria Di Giacomo, Donato Mannina, et al.
Leukemia
|
March 4, 2005
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
S Mariani, M Muraro, F Pantaleoni, et al.
La Radiologia Medica
|
October 24, 2007
Diagnostic accuracy of 64-slice computed tomography coronary angiography in patients with low-to-intermediate risk
F Cademartiri, E Maffei, A Palumbo, et al.
British Journal of Haematology
|
July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Elena Crisà, Daniela Cilloni, Elena M Elli, et al.
La Radiologia Medica
|
October 31, 2008
Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia
F Cademartiri, A Palumbo, E Maffei, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 28, 2007
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms
S Galimberti, G A Palumbo, F Caracciolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
A Palumbo, F Gay, S Bringhen, et al.
Leukemia
|
October 31, 2003
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))
A Palumbo, S Bringhen, A Bertola, et al.
Oncogenesis
|
October 13, 2021
Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
Darko Bosnakovski, Elizabeth T Ener, Mark S Cooper, et al.
Leukemia
|
July 24, 2025
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
Andrea Duminuco, Raj Vaghela, Sukhraj Virdee, et al.
Page
of 50